A history making vaccine is one step closer to making it into doctors offices. A government advisory committee has recommended the FDA approve a vaccine for cervical cancer to use in girls as young as nine.
The vaccine is called Gardasil and it may prevent cervical cancer by spotting strains of the Human Papilomma Virus, or HPV, which can trigger the disease. HPV is a sexually transmitted disease. Merck - the drugs maker says the vaccine works best if it is given to youngsters before they become sexually active and that suggestion is raising some eyebrows.
"We as an organization believe that while the HPV vaccine is a medical advance that should be welcomed, and that the best formula for sexual health is abstinence from sexual activity until marriage and faithfulness within marriage," said Peter Sprigg of Family Research Council.
"I think we need consider this it's not just an STD vaccine, but really its in a sense a cancer prevention vaccine," said Dr. John Barocass.
A Pediatrician studies show the vaccine given in three doses over six months effectively wards off two strains of HPV linked to nearly seventy percent of cervical cancers. The Food and Drug Administration usually approves products recommended by advisory panels. A final FDA decision is expected by June 8.